Protecting Patient Access to Lifesaving COVID–19 Drugs Act of 2021
Summary
Protecting Patient Access to Lifesaving COVID-19 Drugs Act of 2021 This bill requires health insurance plans to cover COVID-19 (i.e., coronavirus disease 2019) antibody treatment at no cost for individuals who have tested positive for the virus.
Bill status
in committee
1 of 4 stages cleared
Introduction
Jan 2021
Committee Review
Floor Vote
President
Introduced Jan 25, 2021
Last action Feb 2, 2021
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
4
Key actions
0
Committee
3
Feb 2, 2021
Committee
Referred to the Subcommittee on Health.
lower
Jan 25, 2021
Committee
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Labor, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
lower
Jan 25, 2021
Committee
Referred to the Subcommittee on Health.
lower
Jan 25, 2021
Introduced
Introduced in House
lower
1 primary · 6 co-sponsors
Sponsors
Ask Maddy
·
AI policy assistant
Ask Maddy about HR 467
Scope: US
Hi! I can help you understand HR 467. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline